Related Experiment Videos
Cytotoxic-drug treatment of lupus nephritis
The New England Journal of Medicine
|August 23, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Role of dietary fish oil supplementation in IgA nephropathy. Mechanistic implications.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2001
n-3 Fatty acids and their role in nephrologic practice.
Current opinion in nephrology and hypertension·2001
The emerging role of omega-3 polyunsaturated fatty acids in the management of patients with IgA nephropathy.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2001
Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo.
Kidney international·2000
Use of fish oil to treat patients with immunoglobulin a nephropathy.
The American journal of clinical nutrition·2000
Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody.
American journal of kidney diseases : the official journal of the National Kidney Foundation·1999
Clinical Uses of Common Genetic Variants Associated with Common Diseases.
The New England journal of medicine·2026
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome.
The New England journal of medicine·2026
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma.
The New England journal of medicine·2026
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis.
The New England journal of medicine·2026
Management of ectopic Cushing syndrome in medullary thyroid carcinoma: from case reports to systematic literature review.
Frontiers in endocrinology·2026
Catatonic Features That May Be Mistaken for Worsening Autism Show Treatment-Associated Improvement: Implications for Later Regression.
medRxiv : the preprint server for health sciences·2026
Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.
bioRxiv : the preprint server for biology·2026